Logo image of ABG.DE

CENCORA INC (ABG.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:ABG - US03073E1055 - Common Stock

292.75 EUR
-2.95 (-1%)
Last: 1/8/2026, 7:00:00 PM
Fundamental Rating

5

Overall ABG gets a fundamental rating of 5 out of 10. We evaluated ABG against 29 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of ABG get a neutral evaluation. Nothing too spectacular is happening here. ABG is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year ABG was profitable.
In the past year ABG had a positive cash flow from operations.
ABG had positive earnings in each of the past 5 years.
ABG had a positive operating cash flow in each of the past 5 years.
ABG.DE Yearly Net Income VS EBIT VS OCF VS FCFABG.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B

1.2 Ratios

ABG has a Return On Assets of 2.03%. This is comparable to the rest of the industry: ABG outperforms 44.83% of its industry peers.
ABG has a better Return On Equity (103.06%) than 100.00% of its industry peers.
With an excellent Return On Invested Capital value of 14.50%, ABG belongs to the best of the industry, outperforming 96.55% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ABG is significantly above the industry average of 6.33%.
Industry RankSector Rank
ROA 2.03%
ROE 103.06%
ROIC 14.5%
ROA(3y)2.36%
ROA(5y)2.55%
ROE(3y)223.66%
ROE(5y)N/A
ROIC(3y)15.04%
ROIC(5y)14.55%
ABG.DE Yearly ROA, ROE, ROICABG.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500 -500

1.3 Margins

ABG's Profit Margin of 0.48% is on the low side compared to the rest of the industry. ABG is outperformed by 62.07% of its industry peers.
ABG's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 1.17%, ABG is not doing good in the industry: 79.31% of the companies in the same industry are doing better.
ABG's Operating Margin has improved in the last couple of years.
ABG has a Gross Margin of 3.51%. This is in the lower half of the industry: ABG underperforms 75.86% of its industry peers.
In the last couple of years the Gross Margin of ABG has grown nicely.
Industry RankSector Rank
OM 1.17%
PM (TTM) 0.48%
GM 3.51%
OM growth 3Y-0.12%
OM growth 5Y1.81%
PM growth 3Y-12.1%
PM growth 5YN/A
GM growth 3Y0.2%
GM growth 5Y5.18%
ABG.DE Yearly Profit, Operating, Gross MarginsABG.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1 -1 2 3

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ABG is creating some value.
ABG has less shares outstanding than it did 1 year ago.
The number of shares outstanding for ABG has been reduced compared to 5 years ago.
The debt/assets ratio for ABG is higher compared to a year ago.
ABG.DE Yearly Shares OutstandingABG.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
ABG.DE Yearly Total Debt VS Total AssetsABG.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

An Altman-Z score of 4.92 indicates that ABG is not in any danger for bankruptcy at the moment.
ABG has a Altman-Z score of 4.92. This is amongst the best in the industry. ABG outperforms 93.10% of its industry peers.
ABG has a debt to FCF ratio of 2.39. This is a good value and a sign of high solvency as ABG would need 2.39 years to pay back of all of its debts.
The Debt to FCF ratio of ABG (2.39) is better than 93.10% of its industry peers.
A Debt/Equity ratio of 5.00 is on the high side and indicates that ABG has dependencies on debt financing.
The Debt to Equity ratio of ABG (5.00) is worse than 82.76% of its industry peers.
Although ABG does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 5
Debt/FCF 2.39
Altman-Z 4.92
ROIC/WACC1.63
WACC8.87%
ABG.DE Yearly LT Debt VS Equity VS FCFABG.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

2.3 Liquidity

ABG has a Current Ratio of 0.90. This is a bad value and indicates that ABG is not financially healthy enough and could expect problems in meeting its short term obligations.
ABG's Current ratio of 0.90 is in line compared to the rest of the industry. ABG outperforms 44.83% of its industry peers.
A Quick Ratio of 0.55 indicates that ABG may have some problems paying its short term obligations.
The Quick ratio of ABG (0.55) is worse than 68.97% of its industry peers.
Industry RankSector Rank
Current Ratio 0.9
Quick Ratio 0.55
ABG.DE Yearly Current Assets VS Current LiabilitesABG.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 16.21% over the past year.
The Earnings Per Share has been growing by 15.14% on average over the past years. This is quite good.
Looking at the last year, ABG shows a quite strong growth in Revenue. The Revenue has grown by 9.31% in the last year.
The Revenue has been growing by 11.09% on average over the past years. This is quite good.
EPS 1Y (TTM)16.21%
EPS 3Y13.21%
EPS 5Y15.14%
EPS Q2Q%14.97%
Revenue 1Y (TTM)9.31%
Revenue growth 3Y10.43%
Revenue growth 5Y11.09%
Sales Q2Q%5.92%

3.2 Future

The Earnings Per Share is expected to grow by 10.82% on average over the next years. This is quite good.
ABG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.02% yearly.
EPS Next Y11.31%
EPS Next 2Y11%
EPS Next 3Y10.78%
EPS Next 5Y10.82%
Revenue Next Year6.24%
Revenue Next 2Y6.43%
Revenue Next 3Y6.47%
Revenue Next 5Y8.02%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ABG.DE Yearly Revenue VS EstimatesABG.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100B 200B 300B 400B
ABG.DE Yearly EPS VS EstimatesABG.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15 20 25

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 21.37 indicates a rather expensive valuation of ABG.
The rest of the industry has a similar Price/Earnings ratio as ABG.
The average S&P500 Price/Earnings ratio is at 27.00. ABG is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 19.20 indicates a rather expensive valuation of ABG.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ABG indicates a slightly more expensive valuation: ABG is more expensive than 65.52% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.70. ABG is around the same levels.
Industry RankSector Rank
PE 21.37
Fwd PE 19.2
ABG.DE Price Earnings VS Forward Price EarningsABG.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ABG is valued a bit more expensive than 75.86% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ABG is valued a bit more expensive than the industry average as 62.07% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 20.67
EV/EBITDA 14.46
ABG.DE Per share dataABG.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 500 1K

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ABG does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of ABG may justify a higher PE ratio.
PEG (NY)1.89
PEG (5Y)1.41
EPS Next 2Y11%
EPS Next 3Y10.78%

4

5. Dividend

5.1 Amount

With a yearly dividend of 0.71%, ABG is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 1.45, ABG has a dividend in line with its industry peers.
With a Dividend Yield of 0.71, ABG pays less dividend than the S&P500 average, which is at 1.94.
Industry RankSector Rank
Dividend Yield 0.71%

5.2 History

On average, the dividend of ABG grows each year by 6.10%, which is quite nice.
Dividend Growth(5Y)6.1%
Div Incr YearsN/A
Div Non Decr YearsN/A
ABG.DE Yearly Dividends per shareABG.DE Yearly Dividends per shareYearly Dividends per share 2021 2022 2025 0.5 1 1.5

5.3 Sustainability

28.12% of the earnings are spent on dividend by ABG. This is a low number and sustainable payout ratio.
The dividend of ABG is growing, but earnings are growing more, so the dividend growth is sustainable.
DP28.12%
EPS Next 2Y11%
EPS Next 3Y10.78%
ABG.DE Yearly Income VS Free CF VS DividendABG.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B
ABG.DE Dividend Payout.ABG.DE Dividend Payout, showing the Payout Ratio.ABG.DE Dividend Payout.PayoutRetained Earnings

CENCORA INC

FRA:ABG (1/8/2026, 7:00:00 PM)

292.75

-2.95 (-1%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-05 2025-11-05/bmo
Earnings (Next)02-03 2026-02-03/bmo
Inst Owners95.74%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner ChangeN/A
Market Cap56.79B
Revenue(TTM)321.33B
Net Income(TTM)1.55B
Analysts80
Price Target333.83 (14.03%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.71%
Yearly Dividend1.91
Dividend Growth(5Y)6.1%
DP28.12%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.78%
Min EPS beat(2)0.41%
Max EPS beat(2)3.15%
EPS beat(4)4
Avg EPS beat(4)3.89%
Min EPS beat(4)0.41%
Max EPS beat(4)6.6%
EPS beat(8)8
Avg EPS beat(8)4.4%
EPS beat(12)12
Avg EPS beat(12)3.83%
EPS beat(16)15
Avg EPS beat(16)3.46%
Revenue beat(2)0
Avg Revenue beat(2)-0.51%
Min Revenue beat(2)-0.67%
Max Revenue beat(2)-0.35%
Revenue beat(4)1
Avg Revenue beat(4)0.16%
Min Revenue beat(4)-1.29%
Max Revenue beat(4)2.93%
Revenue beat(8)4
Avg Revenue beat(8)0.09%
Revenue beat(12)7
Avg Revenue beat(12)0.91%
Revenue beat(16)9
Avg Revenue beat(16)0.67%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)-0.5%
EPS NQ rev (3m)-0.67%
EPS NY rev (1m)-0.22%
EPS NY rev (3m)0.96%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.52%
Revenue NY rev (1m)0.15%
Revenue NY rev (3m)-0.26%
Valuation
Industry RankSector Rank
PE 21.37
Fwd PE 19.2
P/S 0.21
P/FCF 20.67
P/OCF 17.11
P/B 43.97
P/tB N/A
EV/EBITDA 14.46
EPS(TTM)13.7
EY4.68%
EPS(NY)15.24
Fwd EY5.21%
FCF(TTM)14.16
FCFY4.84%
OCF(TTM)17.11
OCFY5.84%
SpS1418.79
BVpS6.66
TBVpS-70.39
PEG (NY)1.89
PEG (5Y)1.41
Graham Number45.3
Profitability
Industry RankSector Rank
ROA 2.03%
ROE 103.06%
ROCE 19.96%
ROIC 14.5%
ROICexc 18.88%
ROICexgc N/A
OM 1.17%
PM (TTM) 0.48%
GM 3.51%
FCFM 1%
ROA(3y)2.36%
ROA(5y)2.55%
ROE(3y)223.66%
ROE(5y)N/A
ROIC(3y)15.04%
ROIC(5y)14.55%
ROICexc(3y)19.39%
ROICexc(5y)18.79%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)20.71%
ROCE(5y)20.04%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-3.36%
ROICexc growth 5Y-5.64%
OM growth 3Y-0.12%
OM growth 5Y1.81%
PM growth 3Y-12.1%
PM growth 5YN/A
GM growth 3Y0.2%
GM growth 5Y5.18%
F-Score6
Asset Turnover4.2
Health
Industry RankSector Rank
Debt/Equity 5
Debt/FCF 2.39
Debt/EBITDA 1.57
Cap/Depr 62.52%
Cap/Sales 0.21%
Interest Coverage 10.51
Cash Conversion 80.48%
Profit Quality 206.36%
Current Ratio 0.9
Quick Ratio 0.55
Altman-Z 4.92
F-Score6
WACC8.87%
ROIC/WACC1.63
Cap/Depr(3y)50.93%
Cap/Depr(5y)61.57%
Cap/Sales(3y)0.18%
Cap/Sales(5y)0.19%
Profit Quality(3y)200.95%
Profit Quality(5y)175.46%
High Growth Momentum
Growth
EPS 1Y (TTM)16.21%
EPS 3Y13.21%
EPS 5Y15.14%
EPS Q2Q%14.97%
EPS Next Y11.31%
EPS Next 2Y11%
EPS Next 3Y10.78%
EPS Next 5Y10.82%
Revenue 1Y (TTM)9.31%
Revenue growth 3Y10.43%
Revenue growth 5Y11.09%
Sales Q2Q%5.92%
Revenue Next Year6.24%
Revenue Next 2Y6.43%
Revenue Next 3Y6.47%
Revenue Next 5Y8.02%
EBIT growth 1Y23.25%
EBIT growth 3Y10.3%
EBIT growth 5Y13.11%
EBIT Next Year23.57%
EBIT Next 3Y12.83%
EBIT Next 5YN/A
FCF growth 1Y6.99%
FCF growth 3Y13.28%
FCF growth 5Y11.79%
OCF growth 1Y11.2%
OCF growth 3Y12.76%
OCF growth 5Y11.92%

CENCORA INC / ABG.DE FAQ

What is the fundamental rating for ABG stock?

ChartMill assigns a fundamental rating of 5 / 10 to ABG.DE.


What is the valuation status for ABG stock?

ChartMill assigns a valuation rating of 2 / 10 to CENCORA INC (ABG.DE). This can be considered as Overvalued.


What is the profitability of ABG stock?

CENCORA INC (ABG.DE) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for ABG stock?

The Price/Earnings (PE) ratio for CENCORA INC (ABG.DE) is 21.37 and the Price/Book (PB) ratio is 43.97.


Is the dividend of CENCORA INC sustainable?

The dividend rating of CENCORA INC (ABG.DE) is 4 / 10 and the dividend payout ratio is 28.12%.